48 results on '"Kaplan, Mariana J"'
Search Results
2. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update
3. Deadliest catch: neutrophil extracellular traps in autoimmunity
4. Cardiovascular disease in systemic lupus erythematosus: an update
5. Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation
6. 18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
7. Abstract 16374: Low Density Granulocytes Associate With Non-Calcified Coronary Plaque in Psoriasis
8. Metabolic abnormalities and oxidative stress in lupus
9. Brief Report: Deficiency of Complement 1r Subcomponent in Early‐Onset Systemic Lupus Erythematosus: The Role of Disease‐Modifying Alleles in a Monogenic Disease
10. Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity
11. 08.43 Antibodies to a subset of citrullinated peptide antigens correlate with neutrophil extracellular trap levels in the sputum of subjects at-risk for future ra
12. Disentangling the role of neutrophil extracellular traps in rheumatic diseases
13. Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
14. The role of neutrophils and NETosis in autoimmune and renal diseases
15. Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2
16. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
17. Brief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood-Onset Systemic Lupus Erythematosus
18. Brief Report: Defining the Nasal Transcriptome in Granulomatosis With Polyangiitis (Wegenerʼs)
19. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2
20. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
21. Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors
22. Interferon-α and Angiogenic Dysregulation in Pregnant Lupus Patients Who Develop Preeclampsia*
23. Neutrophil Extracellular Trap–Derived Enzymes Oxidize High-Density Lipoprotein: An Additional Proatherogenic Mechanism in Systemic Lupus Erythematosus
24. Requirements for “Fire and ICE” Differ Between Animal Models of Autoimmunity: Comment on the Article by Kahlenberg et al
25. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound
26. An Essential Role of Caspase 1 in the Induction of Murine Lupus and Its Associated Vascular Damage
27. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis
28. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis
29. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus
30. Jumbled NETs promote vasculitis
31. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis
32. Neutrophils in the pathogenesis and manifestations of SLE
33. Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis
34. How Does Interferon-α Insult the Vasculature? Let Me Count the Ways
35. Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
36. Management of cardiovascular disease risk in chronic inflammatory disorders
37. Role of dendritic cells in the pathogenesis of systemic lupus erythematosus
38. Is rheumatoid arthritis a risk factor for cardiovascular disease?
39. Dendritic cells and the immunopathogenesis of systemic lupus erythematosus
40. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
41. Women in Academic Rheumatology
42. Plasminogen Activator Inhibitor-1 Is Associated with Impaired Endothelial Function in Women with Systemic Lupus Erythematosus
43. Increased Asymmetric Dimethylarginine and Endothelin 1 Levels in Secondary Raynaudʼs Phenomenon: Implications for Vascular Dysfunction and Progression of Disease
44. Decreased Ras-Mitogen-Activated Protein Kinase Signaling May Cause DNA Hypomethylation in T Lymphocytes From Lupus Patients
45. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients
46. Diffuse Swelling of One Finger in a Patient with Metastatic Breast Cancer
47. THROMBOSIS IN PATIENTS WITH CONNECTIVE TISSUE DISEASES TREATED WITH SPECIFIC CYCLOOXYGENASE 2 INHIBITORS: A Report of Four Cases
48. Systemic Toxicity Following Administration of Sirolimus (Formerly Rapamycin) for Psoriasis: Association of Capillary Leak Syndrome With Apoptosis of Lesional Lymphocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.